- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Search trials
Ensayos clínicos sobre Pericarditis Tuberculosa
Total 1586 resultados
-
International Centre for Diarrhoeal Disease Research...Karolinska Institutet; University of Iceland; National Institute of Diseases of...Terminado
-
Ataulpho de Paiva FoundationBill and Melinda Gates FoundationTerminado
-
Radboud University Medical CenterSanofi; European and Developing Countries Clinical Trials Partnership (EDCTP); National... y otros colaboradoresTerminado
-
University of Cape TownNational Institute of Allergy and Infectious Diseases (NIAID)Desconocido
-
Peter DaleyDalhousie UniversityTerminado
-
International Union Against Tuberculosis and Lung...United States Agency for International Development (USAID)DesconocidoTuberculosisArgelia, Bolivia, Colombia, Guinea, Mozambique, Nepal, Perú, Tanzania, Vietnam
-
University of StellenboschTerminadoVIH/SIDA | Tuberculosis - Tuberculosis | Terapia Antirretroviral, Altamente ActivaSudáfrica
-
Obafemi Awolowo University Teaching HospitalOpen PhilanthropyReclutamientoTuberculosis | Tuberculosis pulmonar | Enfermedad de KochNigeria
-
Foundation for Innovative New Diagnostics, SwitzerlandUniversity of Witwatersrand, South Africa; PD Hinduja Hospital and Medical Research... y otros colaboradoresTerminadoTuberculosis Pulmonar | Tuberculosis resistente a múltiples fármacosMoldavia, República de
-
GlaxoSmithKlineAerasTerminadoTuberculosis | Vacunas contra la tuberculosisSudáfrica, Kenia, Zambia
-
National Institute of Allergy and Infectious Diseases...TerminadoTuberculosis micobacterianaBrasil
-
The University of Texas Health Science Center,...National Institute of Allergy and Infectious Diseases (NIAID)TerminadoTuberculosis micobacterianaEstados Unidos, Colombia, México
-
University of California, San FranciscoJohns Hopkins University; National Heart, Lung, and Blood Institute (NHLBI); Makerere... y otros colaboradoresActivo, no reclutandoVIH | Tuberculosis latente | Tuberculosis | Prevención de la TuberculosisUganda
-
Novartis PharmaceuticalsDisponibleInfecciones por micobacterias no tuberculosas (NTM)Estados Unidos, Canadá
-
Boston UniversityHarvard Medical School (HMS and HSDM); University of Colorado, Denver; National... y otros colaboradoresReclutamientoTuberculosis resistente a múltiples fármacosFilipinas, Vietnam
-
Centre for the AIDS Programme of Research in South...TerminadoTuberculosis resistente a múltiples fármacosSudáfrica
-
Otsuka Pharmaceutical Development & Commercialization...TerminadoTuberculosis resistente a múltiples fármacosCorea, república de, Porcelana, Estonia, Letonia, Perú, Filipinas
-
University Medical Center GroningenDesconocidoTuberculosis resistente a múltiples fármacosSuecia, Reino Unido, Australia, Bielorrusia, Brasil, Grecia, Italia, Letonia, México, Países Bajos, Portugal, Sudáfrica, Tanzania
-
Brigham and Women's HospitalNational Institute of Allergy and Infectious Diseases (NIAID); Bill and Melinda... y otros colaboradoresTerminadoTuberculosis resistente a múltiples fármacosPerú
-
University of California, San DiegoNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...TerminadoTuberculosis | Tuberculosis resistente a múltiples fármacosIndia, Moldavia, República de, Sudáfrica
-
Centers for Disease Control and PreventionBritish Medical Research CouncilReclutamientoTuberculosis latenteAustralia, Estados Unidos, Canadá, Sudáfrica
-
Kaiser PermanenteActivo, no reclutandoTuberculosis latenteEstados Unidos
-
Queen Mary University of LondonUniversity of Cape TownTerminadoTuberculosis latenteSudáfrica
-
Public Health EnglandImperial College London; University College, London; Queen Mary University of London y otros colaboradoresTerminadoTuberculosis latente | TuberculosisReino Unido
-
Services Hospital, LahoreTerminado
-
St George's, University of LondonDesconocidoTuberculosis (TB)Reino Unido
-
Fundació Institut Germans Trias i PujolNational Center for Tuberculosis and Lung Disease, Tbilisi, GeorgiaActivo, no reclutandoTuberculosis | Tuberculosis Pulmonar | Tuberculosis resistente a múltiples fármacos | Cirugía TorácicaGeorgia
-
GlaxoSmithKlineTerminado
-
IDRIWellcome Trust; South African Tuberculosis Vaccine InitiativeTerminadoTuberculosis pulmonarSudáfrica
-
Global Alliance for TB Drug DevelopmentTerminadoTuberculosis pulmonarSudáfrica
-
CepheidCenters for Disease Control and Prevention; AIDS Clinical Trials GroupTerminado
-
Tuberculosis Clinical Diagnostics Research ConsortiumUniversity of Cape TownDesconocidoTuberculosis | Tuberculosis Pulmonar | Tuberculosis MiliarSudáfrica
-
Tuberculosis Clinical Diagnostics Research ConsortiumMakerere UniversityDesconocidoTuberculosis | Tuberculosis Pulmonar | Tuberculosis MiliarUganda
-
Chinese University of Hong KongAún no reclutando
-
Seoul National University HospitalDesconocidoTuberculosis latente | Tuberculosis PulmonarCorea, república de
-
UPECLIN HC FM Botucatu UnespCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Retirado
-
International AIDS Vaccine InitiativeUniversidad de Zaragoza; Biofabri, SLUAún no reclutando
-
University Hospital, MontpellierTerminado
-
Assistance Publique - Hôpitaux de ParisTerminadoTuberculosis extrapulmonarFrancia
-
GlaxoSmithKlineTerminado
-
Thomas SchonKarolinska University Hospital; University Hospital, LinkoepingTerminado
-
University of OxfordImaxioTerminado
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development... y otros colaboradoresReclutamientoTuberculosis | Tuberculosis resistente a la rifampicinaBrasil, India, Sudáfrica, Tanzania, Tailandia
-
University of Cape TownUniversity of Stellenbosch; University of Cape Town Lung Institute; Ospedale San... y otros colaboradoresAún no reclutandoTuberculosis resistente a múltiples fármacosSudáfrica
-
Foundation for Innovative New Diagnostics, SwitzerlandUniversidad Peruana Cayetano Heredia; Kenya Medical Research Institute; V. N. Karazin... y otros colaboradoresActivo, no reclutandoTuberculosis resistente a múltiples fármacosKenia, Perú, Ucrania
-
Foundation for Innovative New Diagnostics, SwitzerlandTerminadoTuberculosis resistente a múltiples fármacosGeorgia, India, Sudáfrica
-
Boston UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Centers for Disease... y otros colaboradoresTerminadoTuberculosis resistente a múltiples fármacosSudáfrica, Perú
-
Dissou AFFOLABILondon School of Hygiene and Tropical Medicine; World Health Organization; Institute... y otros colaboradoresTerminadoTuberculosis resistente a múltiples fármacosBélgica, Benín, Camerún, Congo, República Democrática del, Etiopía, Guinea, Malí, Nigeria, Ruanda, Senegal
-
Partners in HealthHarvard Medical School (HMS and HSDM); Epicentre; Interactive Research and Development y otros colaboradoresTerminadoTuberculosis resistente a múltiples fármacosGeorgia, Armenia, Bangladesh, Bielorrusia, Etiopía, Indonesia, Kazajstán, Kenia, Kirguistán, Lesoto, Birmania, Pakistán, Perú, Sudáfrica
-
University of NamibiaEuropean and Developing Countries Clinical Trials Partnership (EDCTP); Research... y otros colaboradoresReclutamientoCOVID-19 | Seropositividad al VIH | Tuberculosis Pulmonar | Infección tuberculosaNamibia